ArticlebioRxiv : the preprint server for biology2022

In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment.

Jesse W Wotring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.